Broadwater Capital’s AbbVie ABBV Stock Holding History

Broadwater Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.26M	Sell	12,957 -200	-2%	-$43K	2.37%	13
2026 Q1	$3.01M	Hold	13,157	–	–	2.25%	13
2025 Q4	$3.01M	Sell	13,157 -25	-0.2%	-$5.7K	2.25%	13
2025 Q3	$3.05M	Sell	13,182 -2,440,158	-99%	-$497M	2.23%	11
2025 Q2	$2.45B	Buy	2,453,340 +2,439,859	+18,099%	+$453M	1.91%	15
2025 Q1	$2.82M	Sell	13,481 -29	-0.2%	-$5.64K	2.21%	12
2024 Q4	$2.4M	Sell	13,510 -159	-1%	-$29.2K	1.84%	15
2024 Q3	$2.7M	Buy	13,669 +1	+0%	+$187	1.99%	13
2024 Q2	$2.34M	Buy	13,668 +1	+0%	+$166	1.81%	14
2024 Q1	$2.49M	Sell	13,667 -300	-2%	-$51.7K	1.91%	12
2023 Q4	$2.16M	Buy	+13,967	New	+$2.04M	1.7%	14

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Broadwater Capital's ABBV Position: Q2 2026 in Review

Broadwater Capital reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $43K and leaving 12,957 shares worth $3.26M. The position accounts for 2.37% of the portfolio, ranked #13.

Broadwater Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.45B in Q2 2025. 1,771 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Broadwater Capital held 12,957 shares of AbbVie worth $3.26M as of Q2 2026.
Broadwater Capital sold 200 AbbVie shares in Q2 2026, an estimated $43K.
AbbVie made up 2.37% of Broadwater Capital's portfolio in Q2 2026, its #13 holding.
Broadwater Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Broadwater Capital's AbbVie position peaked at $2.45B in Q2 2025.
1,771 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.